Overlap in the clinical features of pneumonia and malaria in African children

T J O'Dempsey1, T F McArdle, B E Laurence

  • 1Medical Research Council Laboratories, Banjul, The Gambia.

Insights

Pneumonia and malaria frequently co-occur in children in developing nations. Differentiating these conditions is crucial for effective treatment and intervention strategies, especially during high malaria transmission seasons.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Pneumonia and malaria are leading causes of child illness and death in developing countries.
  • Simple diagnostic guidelines are proposed for health workers to manage these common childhood diseases.
  • Clinical overlap between pneumonia and malaria complicates accurate diagnosis and treatment.

Purpose of the Study:

  • To investigate the prevalence and clinical overlap of pneumonia and malaria in children in The Gambia.
  • To assess how malaria transmission seasons affect the presentation of clinically suspected pneumonia.

Main Methods:

  • Study conducted on children with clinically suspected pneumonia (cough, difficulty breathing, raised respiratory rate) in The Gambia.
  • Data collected during periods of both high and low malaria transmission.
  • Radiological evidence of pneumonia and presence of malaria parasitaemia were assessed.

Main Results:

  • During high malaria transmission: 33% had radiological pneumonia, 38% had malaria without pneumonia.
  • During low malaria transmission: 48% had radiological pneumonia, 6% had malaria without pneumonia.
  • Significant clinical overlap observed, varying by malaria transmission intensity.

Conclusions:

  • The clinical presentation of pneumonia and malaria significantly overlaps in Gambian children.
  • Case management strategies must account for co-prevalence, especially during high malaria seasons.
  • Accurate differentiation is vital for evaluating disease-specific interventions in co-endemic regions.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...